The Centre for Research on Hawaii Thoracic Oncology Program cancer has reason to celebrate with mesothelioma victims and scientists abroad, as one of its scientists, Haining Yang, MD, Ph.D., recently received a mesothelioma applied research Foundation grant price (MARF) to continue studies on mesothelioma. Yang was selected among 59 international candidates for the grant.
Yang, who received his medical degree from the Medical University of Shandong, will use his grant to study the mechanism of how asbestos causes mesothelioma. Its objective is to develop an effective preventive and therapeutic interventions for the disease. Dr. Yang received an additional grant of Leahi Fund of the Community Foundation of Hawaii. This grant will further support its research and allow the expansion project to include early detection of mesothelioma study in targeted villages in Turkey with a higher incidence of the disease.
Malignant mesothelioma is a very aggressive cancer forms in the lining of body cavities that protect the lungs, heart and stomach. Caused by exposure to asbestos, mesothelioma causes nearly 3,000 deaths in the US each year. Because of the long latency period of the disease, the disease is often terminal with a short life expectancy after diagnosis, unless the very early diagnosis. Hawaii, where Yang is now, is very familiar with the diagnosis of mesothelioma associated with shipyard workers Navy at Pearl Harbor.
The Meso Foundation, a national organization dedicated to eradicating mesothelioma is considered in medical science community for its independent mesothelioma efforts continued to fund new research on mesothelioma. The organization is known for the high quality and funding of innovative research projects worldwide, such as Yang, and they continue to connect with experts mesothelioma patients worldwide. The work of the foundation is funded by meso patients and their families, law firms like Simmons Hanly Conroy, pharmaceutical companies, and other companies interested in asbestos, each working towards a common mission to cure this disease terminal.
For more information, visit the Cancer Research Center of Hawaii.
